The Capton® approach enables production of the therapeutic at the site of damage, localizing treatment, leaving healthy brain tissue untouched.
We started Mercaptor Discoveries because science moves forward on unsteady feet relying on a tiny amount of fortuity mixed into a vast trough of human frailty.
Much of our time and effort has revolved around sulfur biochemistry. One day, we tripped over something unexpected, a result lying outside of our assumptions. The opportunity obliges us to take responsibility for the continued development of what we have learned.
Mercaptor develops drugs to treat damage, dysfunction, and degeneration of the brain. Our molecules, called Captons, are designed to reduce acute and progressive pathologies initiated by neuronal injury. Captons combine three complementary neuroprotective activities into a single small-molecule agent.
The approach is investigational and without precedent. It also promises significant improvements in the performance of a variety of drugs. If Capton dosage is metered and delimited by the pathogenic species it is designed to treat, interference in healthy tissue function will be minimized.
Avoiding the false comfort of certainty, honest scientists sometimes catch a glimpse into the infinite Universe. These rare insights are more likely to help move the world forward than countless years spent trying to prove expectations.